# Perinatal and maternal factors associated with Autism Spectrum Disorder

**Authors:** Susanna Edlund, Nils Haglund, Carl-Gustaf Bornehag, Chris Gennings, Hannu Kiviranta, Alexander Kolevzon, Christian Lindh, Panu Rantakokko, Abraham Reichenberg, Shanna Swan, Karin Källén, Mu-Hong Chen, Mu-Hong Chen, Mu-Hong Chen, Mu-Hong Chen

PMC · DOI: 10.1371/journal.pone.0316968 · 2026-03-18

## TL;DR

This study finds that maternal and perinatal factors like BMI, smoking, and cesarean delivery are linked to autism, with varying effects across different autism subgroups.

## Contribution

The study identifies both shared and subgroup-specific risk factors for autism based on severity, intellectual disability, and family history.

## Key findings

- Higher maternal BMI in early pregnancy increases the likelihood of ASD across all subgroups.
- Maternal smoking and cesarean delivery are more strongly linked to ASD in children without intellectual disability and with less severe ASD.
- Prematurity and low Apgar scores showed weaker or inconsistent associations with ASD.

## Abstract

Autism spectrum disorder (ASD) is a heterogeneous neurodevelopmental condition influenced by both genetic and environmental factors. Prenatal and perinatal exposures have been implicated in ASD etiology, but their influence may vary across clinical subgroups, including subgroups defined by co-occurring intellectual disability (ID).

We conducted a population-based case–control study in southern Sweden including all children diagnosed with ASD before the age of 9, and whose mothers were born in Sweden. Diagnoses were confirmed through detailed medical record review, and information on ASD severity, ID status, and familial ASD were collected for subgroup analyses. A total of 996 ASD cases and 9,960 age- and sex-matched controls were identified from a regional perinatal database. Multivariable logistic regression estimated adjusted odds ratios (aORs) and 95% confidence intervals (CIs) for maternal, obstetric, and neonatal factors.

Higher maternal body mass index (BMI) in early pregnancy was associated with increased likelihood of ASD (adjusted odds ratio [aOR] 1.41–1.76 for overweight and obesity compared with normal weight), with broadly similar associations observed across ASD subgroups defined by severity, intellectual disability, and familial ASD. Maternal smoking in early pregnancy (aOR 1.49, 95% CI 1.22–1.82) and both elective (aOR 1.22, 95% CI 1.01–1.48) and emergency cesarean delivery (aOR 1.40, 95% CI 1.15–1.81) were also associated with higher odds of ASD, with generally stronger associations in children without intellectual disability and in those with less severe ASD. Subgroup-specific associations were observed for maternal epilepsy and gestational diabetes, while prematurity showed weaker associations than anticipated and was mainly observed in severe ASD and non-familial cases. Low Apgar scores at 5 minutes showed no consistent association with ASD.

Multiple maternal and perinatal factors were associated with ASD in this large Swedish cohort. Stratified analyses by ASD severity, ID status, and familial ASD revealed both shared and subgroup-specific association patterns, underscoring the value of considering ASD heterogeneity in studies of neurodevelopmental variation.

## Linked entities

- **Diseases:** Autism Spectrum Disorder (MONDO:0005258), intellectual disability (MONDO:0001071), epilepsy (MONDO:0005027), gestational diabetes (MONDO:0005406)

## Full-text entities

- **Genes:** CDKN2B (cyclin dependent kinase inhibitor 2B) [NCBI Gene 1030] {aka CDK4I, INK4B, MTS2, P15, TP15, p15INK4b}
- **Diseases:** overweight (MESH:D050177), self-injurious behaviors (MESH:D012652), Pregnancy complications (MESH:D011248), cerebral palsy (MESH:D002547), intellectial disability (MESH:D009069), delayed neurodevelopment (MESH:D006968), fetal distress (MESH:D005316), obstetric complications (MESH:D007744), ASD (MESH:D000067877), preeclampsia (MESH:D011225), prematurity (MESH:C536271), weight gain (MESH:D015430), chromosomal abnormalities (MESH:D002869), neurodevelopmental condition (MESH:D020763), anxiety (MESH:D001007), GDM (MESH:D016640), inflammation (MESH:D007249), involuntary (MESH:D014202), ADHD (MESH:D001289), adiposity (MESH:D018205), gestational hypertension (MESH:D046110), hearing or language impairment (MESH:D007806), sensory processing difficulties (MESH:D051346), underweight (MESH:D013851), premature rupture of membranes (MESH:D005322), Epilepsy (MESH:D004827), Autism (MESH:D001321), preterm birth (MESH:D047928), Maternal Epilepsy (MESH:D000079262), depression (MESH:D003866), obese (MESH:D009765), nutritional deficiencies (MESH:D044342), rubella (MESH:D012409), Asperger's syndrome (MESH:D020817), bleeding (MESH:D006470), congenital malformations (OMIM:163000), insulin resistance (MESH:D007333), neurodevelopmental disorders (MESH:D002658), umbilical cord complications (MESH:C536938), labor (MESH:D048949), abnormal placentation (MESH:D010922), Rett syndrome (MESH:D015518), diabetes (MESH:D003920), PDD (MESH:D002659), birth (MESH:D000014), Fragile X syndrome (MESH:D005600), type 1 diabetes (MESH:D003922), ID (MESH:D008607), psychiatric conditions (MESH:D001523), sleep disturbances (MESH:D012893), cognitive impairment (MESH:D003072), neurotoxic (MESH:D020258), smoking (MESH:D015208)
- **Chemicals:** folic acid (MESH:D005492), N (MESH:D009584), topiramate (MESH:D000077236), steroid hormones (MESH:D013256), vitamin D. (MESH:D014807), lamotrigine (MESH:D000077213), PONE-D-24-58795R2 (-), valproate (MESH:D014635)
- **Species:** Homo sapiens (human, species) [taxon 9606], Nicotiana tabacum (American tobacco, species) [taxon 4097]

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12998875/full.md

---
Source: https://tomesphere.com/paper/PMC12998875